TherapeuticsMD
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2008-01-01
- Employees
- 1
- Market Cap
- $22.1M
- Introduction
TherapeuticsMD, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of products for women. The firm's technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. It also manufactures and distr...
Annoveraâ„¢ Drug-Drug Interaction Study
- Conditions
- Interventions
- First Posted Date
- 2020-02-28
- Last Posted Date
- 2021-01-29
- Lead Sponsor
- TherapeuticsMD
- Target Recruit Count
- 67
- Registration Number
- NCT04290390
- Locations
- 🇨🇦
Syneos Health, Quebec City, Quebec, Canada
The Effects of Annoveraâ„¢ and Tampon Co-Usage on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol
- Conditions
- Interventions
- First Posted Date
- 2020-02-17
- Last Posted Date
- 2021-10-29
- Lead Sponsor
- TherapeuticsMD
- Target Recruit Count
- 21
- Registration Number
- NCT04272008
- Locations
- 🇨🇦
Syneos Health, Québec City, Quebec, Canada
🇺🇸University of Pennsylvania Women's Health Clinical Research Center, Philadelphia, Pennsylvania, United States
TXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms of Vulvar and Vaginal Atrophy
- Conditions
- Interventions
- First Posted Date
- 2015-05-20
- Last Posted Date
- 2015-12-14
- Lead Sponsor
- TherapeuticsMD
- Target Recruit Count
- 50
- Registration Number
- NCT02449902
- Locations
- 🇺🇸
Avail Clinical Research, DeLand, Florida, United States
Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women
- Conditions
- Interventions
- First Posted Date
- 2014-10-01
- Last Posted Date
- 2017-05-25
- Lead Sponsor
- TherapeuticsMD
- Target Recruit Count
- 764
- Registration Number
- NCT02253173
- Locations
- 🇺🇸
Women's Clinic of Lincoln, Lincoln, Nebraska, United States
🇺🇸Chattanooga Medical Research, Chattanooga, Tennessee, United States
🇺🇸Medical Affiliated Research Center, Huntsville, Alabama, United States
A Phase 3, Randomized, Three-Cycle, Double-Blind, Placebo-Controlled Study to Evaluate Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding for Secondary Amenorrhea
- First Posted Date
- 2013-12-24
- Last Posted Date
- 2018-05-08
- Lead Sponsor
- TherapeuticsMD
- Target Recruit Count
- 6
- Registration Number
- NCT02019589
- Locations
- 🇺🇸
The Woman's Hospital of Texas Clinical Research Center, Houston, Texas, United States
🇺🇸Precision Clinical Trials/Arizona Wellness Center for Women, Phoenix, Arizona, United States
🇺🇸Precision Trials/New Horizons Women's Care, Chandler, Arizona, United States
A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms
- First Posted Date
- 2013-09-16
- Last Posted Date
- 2019-05-06
- Lead Sponsor
- TherapeuticsMD
- Target Recruit Count
- 1845
- Registration Number
- NCT01942668
- Locations
- 🇺🇸
Accelovance, Melbourne, Florida, United States
🇺🇸Clinical Research of Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸Radiant Research (Chicago), Chicago, Illinois, United States